Your account is not claimed yet. You can sign up with ORCID to claim your account.

Jaleh Fallah

Scopus Author ID Loop profile Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 7

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Hematology (Amsterdam, Netherlands)

Blood advances

This page only lists publications with an associated author ORCID identifier.

Publications

Jaleh Fallah, Chana Weinstock, Gautam U Mehta, Michael H Brave, William F Pierce, Richard Pazdur, Abhilasha Nair, Daniel L Suzman, Laleh Amiri-Kordestani
FDA Approval Summary: Belzutifan for VHL Disease Tumors-Response. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (3) (2023)
Jaleh Fallah, Chana Weinstock, Gautam U Mehta, Michael H Brave, William F Pierce, Richard Pazdur, Abhilasha Nair, Daniel L Suzman, Laleh Amiri-Kordestani
FDA Approval Summary: Belzutifan for VHL Disease Tumors-Response. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (3) (2023)
Jaleh Fallah, Chana Weinstock, Gautam U Mehta, Michael H Brave, William F Pierce, Richard Pazdur, Abhilasha Nair, Daniel L Suzman, Laleh Amiri-Kordestani
FDA Approval Summary: Belzutifan for VHL Disease Tumors-Response. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (3) (2023)
Jaleh Fallah, Michael H Brave, Chana Weinstock, Gautam U Mehta, Diana Bradford, Haley Gittleman, Erik W Bloomquist, Rosane Charlab, Salaheldin S Hamed, Claudia P Miller, Sarah E Dorff, Wiley A Chambers, Bronwyn D Mixter, Jeannette Dinin, William F Pierce, Tiffany K Ricks, Shenghui Tang, Martha Donoghue, Richard Pazdur, Laleh Amiri-Kordestani, Amna Ibrahim, Julia A Beaver
FDA Approval Summary: Belzutifan for von Hippel-Lindau Disease-Associated Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (22) (2022)
Jaleh Fallah, Sundeep Agrawal, Haley Gittleman, Mallorie H Fiero, Sriram Subramaniam, Christy John, Wei Chen, Tiffany K Ricks, Gang Niu, Anthony Fotenos, Min Wang, Kelly Chiang, William F Pierce, Daniel L Suzman, Shenghui Tang, Richard Pazdur, Laleh Amiri-Kordestani, Amna Ibrahim, Paul G Kluetz
FDA Approval Summary: lutetium Lu 177 vipivotide tetraxetan for patients with metastatic castration-resistant prostate cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Jaleh Fallah, Adam J Olszewski
Diagnostic and therapeutic splenectomy for splenic lymphomas: analysis of the National Cancer Data Base. Hematology (Amsterdam, Netherlands) 24 (1) (2019)
Jaleh Fallah, Lindor Qunaj, Adam J Olszewski
Therapy and outcomes of primary central nervous system lymphoma in the United States: analysis of the National Cancer Database. Blood advances 1 (2) (2016)

Jaleh Fallah.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Jaleh Fallah